Top Markets
#1 Purr Purr +59.03%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +35.37%
#4 Kinetiq Kinetiq +28.28%
#5 ApeX ApeX +24.56%
#6 Non-Playable Coin Non-Playable Coin +20.51%
#7 Morpho Morpho +19.21%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.77%
#9 OriginTrail OriginTrail +18.36%
#10 Pudgy Penguins Pudgy Penguins +18.08%
Coin of the day
Purr Purr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Rang in Aktien #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Aktienkurs
$2.72
Zuletzt synchronisiert: 2023-10-19
Marktkapitalisierung
$111.47M
Veränderung (1 Tag)
-0.73%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Talaris Therapeutics, Inc. (TALS)

Kategorie

Healthcare
Preis TALS mit Marktkapitalisierung von B
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
TALS
$2.72
Marktkapitalisierung von Talaris Therapeutics, Inc.(TALS)
Marktkapitalisierung: $111.47M
Mit Stand August 2026 hat Talaris Therapeutics, Inc. eine Marktkapitalisierung von $111.47M. Das macht Talaris Therapeutics, Inc. laut unseren Daten zum 21258th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Talaris Therapeutics, Inc. von 2021 bis 2026
TALS im Vergleich zu den Top 5 der beliebtesten stocks
Preis für TALS Vermögenswert B Marktkapitalisierung von B Ergebnisse
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$127,168 $111.47M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,675,210.91%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$110,950 $111.47M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,078,953.24%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$101,573 $111.47M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,734,210.45%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$87,671.72 $111.47M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,223,124.84%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$68,151.57 $111.47M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,505,472.44%